Properties (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Psychologist
|
| gptkbp:age |
between 40 and 70
|
| gptkbp:associated_with |
frontotemporal dementia
|
| gptkbp:causedBy |
muscle weakness
mutations in C9orf72 gene mutations in SOD1 gene mutations_in_TARDBP_gene |
| gptkbp:diseaseResistance |
clinical examination
electromyography |
| gptkbp:geneticDiversity |
familial_ALS
|
| gptkbp:has_a |
gptkb:sporadic_ALS
3 to 5 years after diagnosis |
| gptkbp:has_a_focus_on |
neuroscience research
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALS
|
| gptkbp:impact |
speech
stress motor neurons swallowing physical trauma |
| gptkbp:influenced |
environmental factors
genetic factors |
| gptkbp:introduced |
gptkb:Jean-Martin_Charcot
|
| gptkbp:is_a_subject_of |
educational programs
social media campaigns biographies clinical guidelines documentaries fundraising events research grants scientific publications advocacy campaigns patient support groups medical conferences awareness initiatives patient advocacy organizations |
| gptkbp:is_characterized_by |
muscle cramps
spasticity fasciculations progressive muscle atrophy |
| gptkbp:is_featured_in |
multiple sclerosis
|
| gptkbp:is_governed_by |
physical therapy
occupational therapy speech therapy |
| gptkbp:is_part_of |
motor neuron diseases
|
| gptkbp:is_recognized_for |
gptkb:World_Health_Organization
|
| gptkbp:is_studied_in |
clinical trials
neurologists |
| gptkbp:is_supported_by |
gptkb:ALS_Association
gptkb:MDA_(Muscular_Dystrophy_Association) |
| gptkbp:is_used_in |
anxiety
depression men than women symptomatic therapies |
| gptkbp:leads |
respiratory failure
paralysis cognitive changes |
| gptkbp:previousName |
amyotrophic lateral sclerosis
|
| gptkbp:related_to |
gptkb:Lou_Gehrig's_disease
|
| gptkbp:worksWith |
riluzole
|